{"entity":{"type":"insider","cik":"0001314760","url":"/insider/0001314760","json_url":"/insider/0001314760.json","name":"Forbes William P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":23,"first":"2007-07-06","last":"2023-11-21","span_basis":"filed_date"},"name_variants":[{"name":"Forbes William P","source":"filing","n_filings":23,"first_seen":"2007-07-06","last_seen":"2023-11-21"}],"transactions":[{"id":8000018,"accession":"0001209191-23-056198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056198","line_url":"/filing/0001209191-23-056198#line-1","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.09,"price_display":"1.09","price_state":"stated","total_value":27250.0,"total_display":"27,250.00","total_whole":"27,250","shares_owned_after":79000.0,"shares_owned_after_display":"79,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-21","scope":"insider"},{"id":8630977,"accession":"0001209191-23-055948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055948","line_url":"/filing/0001209191-23-055948#line-1","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.9399,"price_display":"0.94","price_state":"stated","total_value":46995.0,"total_display":"46,995.00","total_whole":"46,995","shares_owned_after":54000.0,"shares_owned_after_display":"54,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8447790,"accession":"0001493152-23-010620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-010620","line_url":"/filing/0001493152-23-010620#line-1","is_derivative":false,"issuer_cik":"0001314760","issuer_name":"Beyond Air, Inc.","issuer_ticker":"XAIR","issuer_name_source":null,"issuer_url":"/issuer/0001314760","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.67,"price_display":"6.67","price_state":"stated","total_value":33350.0,"total_display":"33,350.00","total_whole":"33,350","shares_owned_after":14855.0,"shares_owned_after_display":"14,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-31","filed_date":"2023-04-03","scope":"insider"},{"id":8632604,"accession":"0001493152-23-008243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-008243","line_url":"/filing/0001493152-23-008243#line-1","is_derivative":false,"issuer_cik":"0001314760","issuer_name":"Beyond Air, Inc.","issuer_ticker":"XAIR","issuer_name_source":null,"issuer_url":"/issuer/0001314760","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.46,"price_display":"6.46","price_state":"stated","total_value":32300.0,"total_display":"32,300.00","total_whole":"32,300","shares_owned_after":9855.0,"shares_owned_after_display":"9,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-20","scope":"insider"},{"id":8080610,"accession":"0001493152-19-017756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-19-017756","line_url":"/filing/0001493152-19-017756#line-1","is_derivative":false,"issuer_cik":"0001314760","issuer_name":"Beyond Air, Inc.","issuer_ticker":"XAIR","issuer_name_source":null,"issuer_url":"/issuer/0001314760","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4855.0,"shares_display":"4,855","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":25003.25,"total_display":"25,003.25","total_whole":"25,003","shares_owned_after":4855.0,"shares_owned_after_display":"4,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-11-15","scope":"insider"},{"id":8534422,"accession":"0001209191-15-025204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-025204","line_url":"/filing/0001209191-15-025204#line-1","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (President, Medical R&D and CDO)","role_mark":"O","role_mark_label":"Officer (President, Medical R&D and CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Medical R&D and CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42880.0,"shares_display":"42,880","price_per_share":157.84,"price_display":"157.84","price_state":"stated","total_value":6768179.2,"total_display":"6,768,179.20","total_whole":"6,768,179","shares_owned_after":51714.0,"shares_owned_after_display":"51,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-11","scope":"insider"},{"id":8534302,"accession":"0001209191-15-024131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-024131","line_url":"/filing/0001209191-15-024131#line-1","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":157.96,"price_display":"157.96","price_state":"stated","total_value":3159200.0,"total_display":"3,159,200.00","total_whole":"3,159,200","shares_owned_after":94594.0,"shares_owned_after_display":"94,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-06","filed_date":"2015-03-09","scope":"insider"},{"id":6977072,"accession":"0001209191-14-068898","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-068898","line_url":"/filing/0001209191-14-068898#line-3","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11079.0,"shares_display":"11,079","price_per_share":95.05,"price_display":"95.05","price_state":"stated","total_value":1053058.95,"total_display":"1,053,058.95","total_whole":"1,053,059","shares_owned_after":125591.0,"shares_owned_after_display":"125,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":6586399,"accession":"0001209191-14-002821","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-002821","line_url":"/filing/0001209191-14-002821#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":90.06,"price_display":"90.06","price_state":"stated","total_value":720480.0,"total_display":"720,480.00","total_whole":"720,480","shares_owned_after":81573.0,"shares_owned_after_display":"81,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-08","filed_date":"2014-01-10","scope":"insider"},{"id":4565983,"accession":"0001209191-13-038069","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-038069","line_url":"/filing/0001209191-13-038069","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":70.9275,"price_display":"70.93","price_state":"stated","total_value":851130.0,"total_display":"851,130.00","total_whole":"851,130","shares_owned_after":93424.0,"shares_owned_after_display":"93,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-24","filed_date":"2013-07-26","scope":"insider","n_lines":3},{"id":4417047,"accession":"0001209191-13-021277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-021277","line_url":"/filing/0001209191-13-021277#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8673.0,"shares_display":"8,673","price_per_share":49.37,"price_display":"49.37","price_state":"stated","total_value":428186.01,"total_display":"428,186.01","total_whole":"428,186","shares_owned_after":71518.0,"shares_owned_after_display":"71,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-10","filed_date":"2013-04-12","scope":"insider"},{"id":2820119,"accession":"0001209191-12-029509","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-029509","line_url":"/filing/0001209191-12-029509","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":51.6139,"price_display":"51.61","price_state":"stated","total_value":516139.0,"total_display":"516,139.00","total_whole":"516,139","shares_owned_after":79250.0,"shares_owned_after_display":"79,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-08","filed_date":"2012-05-21","scope":"insider","n_lines":2},{"id":3395504,"accession":"0001209191-12-010558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-010558","line_url":"/filing/0001209191-12-010558#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4297.0,"shares_display":"4,297","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":214850.0,"total_display":"214,850.00","total_whole":"214,850","shares_owned_after":55637.0,"shares_owned_after_display":"55,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-13","filed_date":"2012-02-15","scope":"insider"},{"id":2318641,"accession":"0001209191-12-008179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-008179","line_url":"/filing/0001209191-12-008179#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":259.0,"shares_display":"259","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":12950.0,"total_display":"12,950.00","total_whole":"12,950","shares_owned_after":55637.0,"shares_owned_after_display":"55,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-03","filed_date":"2012-02-07","scope":"insider"},{"id":3421119,"accession":"0001209191-12-004475","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-12-004475","line_url":"/filing/0001209191-12-004475#line-4","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125.0,"shares_display":"125","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":6250.0,"total_display":"6,250.00","total_whole":"6,250","shares_owned_after":55637.0,"shares_owned_after_display":"55,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-18","filed_date":"2012-01-19","scope":"insider"},{"id":3421114,"accession":"0001209191-12-004475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-004475","line_url":"/filing/0001209191-12-004475#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1119.0,"shares_display":"1,119","price_per_share":50.059,"price_display":"50.06","price_state":"stated","total_value":56016.021,"total_display":"56,016.02","total_whole":"56,016","shares_owned_after":55637.0,"shares_owned_after_display":"55,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-17","filed_date":"2012-01-19","scope":"insider"},{"id":8834026,"accession":"0001209191-11-039092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-039092","line_url":"/filing/0001209191-11-039092#line-1","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":39.5972,"price_display":"39.60","price_state":"stated","total_value":514763.6,"total_display":"514,763.60","total_whole":"514,764","shares_owned_after":58143.0,"shares_owned_after_display":"58,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-07","filed_date":"2011-07-11","scope":"insider"},{"id":9074681,"accession":"0001209191-11-029421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-029421","line_url":"/filing/0001209191-11-029421#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (EVP Research&Devel & CDO)","role_mark":"O","role_mark_label":"Officer (EVP Research&Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research&Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.3493,"price_display":"40.35","price_state":"stated","total_value":806986.0,"total_display":"806,986.00","total_whole":"806,986","shares_owned_after":80355.0,"shares_owned_after_display":"80,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-18","scope":"insider"},{"id":7442060,"accession":"0001209191-10-054448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-054448","line_url":"/filing/0001209191-10-054448#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (V.P. Research& Devel & CDO)","role_mark":"O","role_mark_label":"Officer (V.P. Research& Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P. Research& Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0053,"price_display":"40.01","price_state":"stated","total_value":400053.0,"total_display":"400,053.00","total_whole":"400,053","shares_owned_after":57657.0,"shares_owned_after_display":"57,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-10","filed_date":"2010-11-12","scope":"insider"},{"id":7639125,"accession":"0001209191-10-046584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-046584","line_url":"/filing/0001209191-10-046584#line-1","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (V.P. Research& Devel & CDO)","role_mark":"O","role_mark_label":"Officer (V.P. Research& Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P. Research& Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10695.0,"shares_display":"10,695","price_per_share":40.4963,"price_display":"40.50","price_state":"stated","total_value":433107.9285,"total_display":"433,107.93","total_whole":"433,108","shares_owned_after":57657.0,"shares_owned_after_display":"57,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-15","filed_date":"2010-09-16","scope":"insider"},{"id":7654698,"accession":"0001209191-10-022545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-022545","line_url":"/filing/0001209191-10-022545#line-2","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (V.P. Research& Devel & CDO)","role_mark":"O","role_mark_label":"Officer (V.P. Research& Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P. Research& Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0251,"price_display":"40.03","price_state":"stated","total_value":400251.0,"total_display":"400,251.00","total_whole":"400,251","shares_owned_after":60883.0,"shares_owned_after_display":"60,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-14","filed_date":"2010-04-16","scope":"insider"},{"id":7692724,"accession":"0001209191-10-020625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-020625","line_url":"/filing/0001209191-10-020625#line-1","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (V.P. Research& Devel & CDO)","role_mark":"O","role_mark_label":"Officer (V.P. Research& Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P. Research& Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1879.0,"shares_display":"1,879","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":71402.0,"total_display":"71,402.00","total_whole":"71,402","shares_owned_after":60883.0,"shares_owned_after_display":"60,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-01","filed_date":"2010-04-05","scope":"insider"},{"id":5655481,"accession":"0001209191-09-058795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-058795","line_url":"/filing/0001209191-09-058795#line-1","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (V.P. Research& Devel & CDO)","role_mark":"O","role_mark_label":"Officer (V.P. Research& Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P. Research& Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":125000.0,"total_display":"125,000.00","total_whole":"125,000","shares_owned_after":62762.0,"shares_owned_after_display":"62,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-28","scope":"insider"},{"id":7913668,"accession":"0001209191-07-041531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-041531","line_url":"/filing/0001209191-07-041531","is_derivative":false,"issuer_cik":"0001009356","issuer_name":"SALIX PHARMACEUTICALS LTD","issuer_ticker":"SLXP","issuer_name_source":null,"issuer_url":"/issuer/0001009356","owner_cik":"0001314760","owner_name":"Forbes William P","owner_display_name":"Forbes William P","owner_url":"/insider/0001314760","role":"Officer (V.P. Research& Devel & CDO)","role_mark":"O","role_mark_label":"Officer (V.P. Research& Devel & CDO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P. Research& Devel & CDO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1113.0,"shares_display":"1,113","price_per_share":12.328203054806828,"price_display":"12.33","price_state":"stated","total_value":13721.29,"total_display":"13,721.29","total_whole":"13,721","shares_owned_after":26332.0,"shares_owned_after_display":"26,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-03","filed_date":"2007-07-06","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818033","name":"HERON THERAPEUTICS, INC. /DE/","url":"/issuer/0000818033","role":"Officer (EVP, Chief Development Officer)","n_filings":2,"first_seen":"2023-11-20","last_seen":"2023-11-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001641631","name":"Beyond Air, Inc.","url":"/issuer/0001641631","role":"Director","n_filings":3,"first_seen":"2019-11-15","last_seen":"2023-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001009356","name":"SALIX PHARMACEUTICALS LTD","url":"/issuer/0001009356","role":"Officer (President, Medical R&D and CDO)","n_filings":18,"first_seen":"2007-07-06","last_seen":"2015-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001314760","retrieved_at":"2026-08-22T16:34:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}